A 58-year-old ex-smoker with a 40-pack-year history is diagnosed with stable COPD, GOLD stage 2, with persistent exertional dyspnoea despite short-acting bronchodilator use. He has had one moderate exacerbation in the last year managed in the community. According to the COPD-X Plan, which is the most appropriate next step in pharmacological management?